Give your patients a reason to smile.

Wishbone Biotech's mission is to revolutionise bone regeneration for dental implants by providing superior bone graft substitute products using innovative technologies and forward-thinking clinical approaches. 

We extract and deactivate all proteins, including prions, from our bovine bone graft using cutting-edge, patent-protected manufacturing technology. Our manufacturing process retains the natural micro and nano-topography of the native bone, enhances bone graft mineralization, and promotes effective implant osteointegration. We have named this groundbreaking product "W-Bone".

We are pleased to provide a state-of-the-art facility for Research and Development, Production, and Quality Control, located here in the province of Liège, Belgium. Our facility complies with ISO 13485 and has an ISO 7-certified cleanroom.

Leadership Team

  • Emilie Dory, CEO

    Emilie has more than nine years of experience developing and producing medical devices. After graduating as a bioengineer, she occupied different positions in the MedTech industry over the years, such as R&D Engineer, R&D Manager and COO.

  • Daniel Bee, Head of Sales

    Daniel has held leadership positions in medical device companies with responsibility for commercial operations and technical/scientific teams in the UK, Sweden, Germany, Belgium, France, Australia and North America.

    He has achieved market leadership positions and secured exclusive global corporate partnership agreements in medical devices sectors across EMEA, Japan and the USA

The Founders

  • Eric Rompen

    Eric Rompen is a full-time Professor at the University of Liege and the head of the department of Periodontology – Dental Surgery. He is also coordinating the European University Certificate of oral implantology. His favorite subjects of clinical and experimental research are biomaterials, bone regeneration, biological interface implant/soft issue and osseointegration. His clinical work is focused on gingival muco surgery and implantology.

  • France Lambert

    France Lambert graduated from the University of Liege in Periodontology, where she continued to obtain a PhD in the same subject. She has also completed a fellowship program in oral implantology at the prestigious Harvard School of Dental Medicine as well as the University of Washington.

    She is currently Head of Clinic in the Periodontology and Oral Surgery Departement at the University of Liege. Her clinical work is focused exclusively on implantology, mucogingival surgery and periodontics. Her scientific research areas target different aspects of the use of biomaterial and dental implants

  • Geoffrey Lecloux

    Geoffrey Lecloux received a degree in dentistry at the University of Liege. After an assistantship, he received the title of specialist in oral rehabilitation. He specialized in the field of Periodontology and trained at the DU of Paris VII University. He also received the Implant and Periodontology Specialist degree at the University of Liege.

    He is currently Head of Clinic in the Prof. Rompen’s Periodontology Dental Surgery service.

Board of Directors

  • Marc Foidart

    CHAIRMAN

  • Simon Alexandre

    NON-EXECUTIVE

  • Thomas Lienard

    NON-EXECUTIVE, INDEPENDENT

  • Prof. Eric Rompen

    NON-EXECUTIVE, CO-FOUNDER